Mass influence of DOTA-Rituximab in the radiolabelling with Lu-177

dc.creatorARAUJO, ELAINE B. de
dc.creatorMASSICANO, ADRIANA V.F.
dc.creatorPUJATTI, PRISCILLA B.
dc.date2011
dc.date2014-08-06T13:47:53Z
dc.date2014-08-06T14:03:13Z
dc.date2014-08-06T13:47:53Z
dc.date2014-08-06T14:03:13Z
dc.date.accessioned2023-09-28T12:43:28Z
dc.date.available2023-09-28T12:43:28Z
dc.identifierhttp://repositorio.ipen.br/handle/123456789/8892
dc.identifier54
dc.identifierano 14
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8979285
dc.relationALASBIMN Journal
dc.rightsopenAccess
dc.sourceApresentado em: Congresso de ALASBINN, Porto de Galinhas, 28 de setembro - 1 de outubro, 2011
dc.subjectradiopharmaceuticals
dc.subjectlutetium 177
dc.subjectlabelling
dc.subjecthodgkins disease
dc.subjectmonoclonal antibodies
dc.subjectpurification
dc.subjectradiochemical analysis
dc.subjectradioimmunotherapy
dc.subjectneoplasms
dc.subjectmetastases
dc.titleMass influence of DOTA-Rituximab in the radiolabelling with Lu-177
dc.typeResumos em peri??dicos
dc.coverageN


Este ítem pertenece a la siguiente institución